Drug label update: Glipizide
Official structured record identifier: 252ba4e0-8dc3-43e3-be00-32570dc095bd.
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- openFDA Drug Labels
- Region
- USA
- Scope
- Regulatory
- Published
- July 13, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Official structured record identifier: 252ba4e0-8dc3-43e3-be00-32570dc095bd.
Source route
Continue on open.fda.gov
Leave the platform to read the original full article on the publisher site.
Source: openFDA Drug Labels
Scope: Regulatory
Related coverage
More related coverage
JCVI statement on meningococcal B vaccination in older children and young adults, 16 July 2026
Statement setting out the recommendation from the Joint Committee on Vaccination and Immunisation (J...
Pneumococcal disease: cases caused by serotypes covered by PCV13
Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevena...
Pneumococcal disease: cases caused by serotypes not covered by PCV13
Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Pre...
Alternative Provider Medical Services (APMS) Directions
Directions for the NHS from the Secretary of State for Health and Social Care relating to Alternativ...